BMP2/ALKs signaling system in diabetic retinopathy
BMP2/ALKs信号系统在糖尿病视网膜病变中的作用
基本信息
- 批准号:10558709
- 负责人:
- 金额:$ 35.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-01 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:Activin ReceptorActivinsAddressAdultAffectAffinityAgeAttenuatedAutoimmunityBMP2 geneBMP4BMPR2 geneBasement membraneBindingBlindnessBlood PreservationBlood VesselsBlood capillariesBlood-Retinal BarrierClinicalComplications of Diabetes MellitusDataDepositionDevelopmentDiabetes MellitusDiabetic RetinopathyDiabetic mouseEndothelial CellsEndotheliumEventExtracellular MatrixExtracellular Matrix ProteinsFibronectinsFunctional disorderGenesGenomeGlucoseGoalsGrowth FactorHumanInflammatoryKnockout MiceKnowledgeLinkMAP Kinase GeneMediatingMissionModalityMolecularMonitorMusNational Eye InstituteOutcomePathogenesisPathway interactionsPermeabilityPhosphotransferasesPlayPreventionRetinaRoleSamplingSerumSignal TransductionStreptozocinSystemTestingTherapeuticTransforming Growth Factor betaTransforming Growth FactorsUnited States National Institutes of HealthUp-RegulationVascular Endothelial Growth FactorsVisualattenuationblood glucose regulationbone morphogenetic protein receptor type Ibone morphogenetic protein receptorscohortconditional knockoutconnective tissue growth factorcytokinediabeticdiabetic patientendothelial dysfunctiongenetic manipulationhuman subjectimprovedinhibitorintravitreal injectionlaser photocoagulationmacular edemamouse modelnew therapeutic targetp38 Mitogen Activated Protein Kinaseparticipant enrollmentpharmacologicphenomepreventprospectivereceptorrecruitretina blood vessel structureretinal damageside effecttherapeutic target
项目摘要
Summary
Breakdown of the blood-retinal barrier (BRB) and thickening of the endothelial cell basement membrane due to
deposition of extracellular matrix (ECM) are early events in the pathogenesis of diabetic retinopathy (DR).
Current treatments are limited by significant side effects, including ECM deposition. Bone morphogenetic protein-
2 (BMP2), a secreted cytokine belonging to the TGF-β superfamily initiates signaling through activin receptors
like kinases (Alk1, 2, 3, and 6) with high affinity to Alk2 and 3. The goal of this project is to test the hypothesis
that in diabetes, BMP2 compromises BRB and induces ECM formation through the endothelial Alk2/3-dependent
mechanism. Our hypothesis is supported by compelling preliminary findings that retinal and circulating BMP2
are upregulated in diabetic humans and mice, as well as in human retinal endothelial cells (HRECs) subjected
to high glucose (HG). Importantly, BMP2 inhibitors attenuate the permeability and ECM deposition effect of HG
in HRECs. Moreover, BMP2 activates the canonical and non-canonical pathways (smad/Runx2 and p38
MAPK/NFB, respectively) in HRECs. Our hypothesis predicts that in diabetes BMP2 activates smad and p38
MAPK pathways integrate at wnt/-catenin to induce hyperpermeability and ECM deposition. We will test the
following specific aims: 1. Activated BMP2/Alks signaling system contributes to retinal endothelial cell
dysfunction in DR: We will correlate changes in circulating levels of BMPs to the development of DR using
serum samples from a large cohort of diabetic patients enrolled in the Phenome and Genome of Diabetes
Autoimmunity (PAGODA) study and have been prospectively monitored for the development of diabetic
complications including DR in the last 15 years. Using a streptozotocin-induced diabetic mouse model, and
HRECs subjected to HG, we will determine the levels and distribution of BMP2 signaling system (BMP2, BMP4,
BMP receptors, smad1/5/9, Runx2, and negative regulators of BMP2 such as noggin and BMP-binding endothelial
regulator (BMPER). Subsequently, we will study the effects of pharmacological inhibition or genetic manipulation
of the BMP2/Alks system on BRB function, and ECM. We will use endothelial Alk2/3 conditional knockout mice
developed within our lab and commercially available BMPER-deficient mice (BMPER+/−) and; 2. Both canonical
and non-canonical pathways contribute to BMP2-mediated retinal endothelial cell dysfunction in DR: We
will test a) the effect of modulation of BMP2/Alks signaling on the smad1/5/9 and p38/NFB pathways under normal
or diabetic conditions, b) the effect of inhibition of smad1/5/9 or p38/NFB signaling on diabetes or BMP2-induced
permeability and ECM deposition, and c) the role of the wnt/catenin pathway as a potential downstream
target from both p38/NFB and smad1/5/9 pathways to mediate retinal microvascular damage induced by BMP2.
The translational significance of this proposal is the therapeutic potential of inhibition of BMP2/Alks signaling
to improve the visual outcomes in DR with the ultimate goal of overcoming the limiting factors of current
therapies in the prevention of ECM deposition.
总结
血-视网膜屏障(BRB)的破坏和内皮细胞基底膜的增厚,
细胞外基质(ECM)沉积是糖尿病视网膜病变(DR)发病的早期事件。
目前的治疗受到显著副作用的限制,包括ECM沉积。骨形态发生蛋白-
2(BMP 2),一种属于TGF-β超家族的分泌型细胞因子,通过激活素受体启动信号传导
类似激酶(Alk 1、2、3和6),对Alk 2和3具有高亲和力。这个项目的目标是检验这个假设
在糖尿病中,BMP 2通过内皮Alk 2/3依赖性的细胞外基质诱导BRB和ECM形成。
机制我们的假设得到了令人信服的初步发现的支持,视网膜和循环中的BMP 2
在糖尿病人和小鼠中,以及在经历了以下过程的人视网膜内皮细胞(HREC)中上调:
高血糖(HG)。重要的是,BMP 2抑制剂减弱HG的渗透性和ECM沉积作用,
在人权和环境委员会。此外,BMP 2激活经典和非经典途径(smad/Runx 2和p38
MAPK/NF κ B(分别为B)。我们的假设预测,在糖尿病中,BMP 2激活smad和p38,
MAPK通路在wnt/β-连环蛋白处整合以诱导高通透性和ECM沉积。我们将测试
具体目标如下:1。激活的BMP-2/Alks信号系统促进视网膜内皮细胞
DR的功能障碍:我们将使用
来自糖尿病表型和基因组的糖尿病患者大队列的血清样本
自身免疫(PAGODA)研究,并已前瞻性监测糖尿病的发展
包括DR在内的并发症。使用链脲佐菌素诱导的糖尿病小鼠模型,以及
HREC经HG处理后,我们将测定BMP 2信号系统(BMP 2,BMP 4,
BMP受体、smad 1/5/9、Runx 2和BMP 2的负调节因子,如头蛋白和BMP结合内皮细胞
调节器(BMPER)。随后,我们将研究药物抑制或遗传操作的影响
BMP 2/Alks系统的BRB功能和ECM。我们将使用内皮Alk 2/3条件性敲除小鼠
在我们的实验室内开发和商业上可获得的BMPER缺陷小鼠(BMPER+/−)和; 2.既规范
和非经典途径有助于DR中BMP 2介导的视网膜内皮细胞功能障碍:我们
将测试a)在正常条件下BMP 2/Alks信号传导的调节对smad 1/5/9和p38/NF κ B B通路的影响
B)抑制smad 1/5/9或p38/NF κ B B信号传导对糖尿病或BMP 2诱导的糖尿病的影响,
c)wnt/β-catenin通路作为潜在的下游调节因子的作用,
从p38/NF κ B B和smad 1/5/9途径靶向介导由BMP 2诱导的视网膜微血管损伤。
该提议的翻译意义在于抑制BMP 2/Alks信号传导的治疗潜力
改善DR中的视觉结果,最终目标是克服电流的限制因素
预防ECM沉积的治疗。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Bone Morphogenetic Proteins and Diabetic Retinopathy.
- DOI:10.3390/biom11040593
- 发表时间:2021-04-18
- 期刊:
- 影响因子:5.5
- 作者:Elmasry K;Habib S;Moustafa M;Al-Shabrawey M
- 通讯作者:Al-Shabrawey M
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mohamed Al-Sayed Al-Shabrawey其他文献
Mohamed Al-Sayed Al-Shabrawey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mohamed Al-Sayed Al-Shabrawey', 18)}}的其他基金
BMP2/ALKs signaling system in diabetic retinopathy
BMP2/ALKs信号系统在糖尿病视网膜病变中的作用
- 批准号:
10457087 - 财政年份:2021
- 资助金额:
$ 35.63万 - 项目类别:
BMP2/ALKs signaling system in diabetic retinopathy
BMP2/ALKs信号系统在糖尿病视网膜病变中的作用
- 批准号:
10333334 - 财政年份:2021
- 资助金额:
$ 35.63万 - 项目类别:
BMP2/ALKs signaling system in diabetic retinopathy
BMP2/ALKs信号系统在糖尿病视网膜病变中的作用
- 批准号:
9886394 - 财政年份:2020
- 资助金额:
$ 35.63万 - 项目类别:
BMP2/ALKs signaling system in diabetic retinopathy
BMP2/ALKs信号系统在糖尿病视网膜病变中的作用
- 批准号:
10093052 - 财政年份:2020
- 资助金额:
$ 35.63万 - 项目类别:
Role of lipoxygenase pathway in early microvascular dysfunction during diabetic r
脂氧合酶途径在糖尿病患者早期微血管功能障碍中的作用
- 批准号:
8633459 - 财政年份:2013
- 资助金额:
$ 35.63万 - 项目类别:
Role of lipoxygenase pathway in early microvascular dysfunction during diabetic r
脂氧合酶途径在糖尿病患者早期微血管功能障碍中的作用
- 批准号:
8483282 - 财政年份:2013
- 资助金额:
$ 35.63万 - 项目类别:
相似海外基金
Effects of activins and activin-binding proteins on fetal lung development
激活素和激活素结合蛋白对胎儿肺发育的影响
- 批准号:
23K08875 - 财政年份:2023
- 资助金额:
$ 35.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeting Activins to treat cachexia
靶向激活素治疗恶病质
- 批准号:
nhmrc : 1078907 - 财政年份:2015
- 资助金额:
$ 35.63万 - 项目类别:
Project Grants
Targeting Activins to treat cachexia
靶向激活素治疗恶病质
- 批准号:
nhmrc : GNT1078907 - 财政年份:2015
- 资助金额:
$ 35.63万 - 项目类别:
Project Grants
INTERACTIONS OF ACTIVINS AND BMP WITH THEIR RECEPTORS
激活素和 BMP 与其受体的相互作用
- 批准号:
7537247 - 财政年份:2007
- 资助金额:
$ 35.63万 - 项目类别:
INTERACTIONS OF ACTIVINS AND BMP WITH THEIR RECEPTORS
激活素和 BMP 与其受体的相互作用
- 批准号:
6849106 - 财政年份:2003
- 资助金额:
$ 35.63万 - 项目类别:
ROLE OF ACTIVINS IN BRANCHING MORPHOGENESIS OF THE PROSTATE AND OTHER ORGANS
激活素在前列腺和其他器官分支形态发生中的作用
- 批准号:
nhmrc : 7191 - 财政年份:2001
- 资助金额:
$ 35.63万 - 项目类别:
Early Career Fellowships
Biology of activins in fetoplacental hypoxia
胎儿胎盘缺氧中激活素的生物学
- 批准号:
nhmrc : 143769 - 财政年份:2001
- 资助金额:
$ 35.63万 - 项目类别:
NHMRC Postgraduate Scholarships
Roles of inhibins, activins, and follistation in reproductive systems.
抑制素、激活素和卵泡在生殖系统中的作用。
- 批准号:
10460135 - 财政年份:1998
- 资助金额:
$ 35.63万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
FUNCTIONAL ANALYSIS OF ACTIVINS DURING DEVELOPMENT
发育过程中激活素的功能分析
- 批准号:
6125677 - 财政年份:1994
- 资助金额:
$ 35.63万 - 项目类别:
FUNCTIONAL ANALYSIS OF ACTIVINS DURING DEVELOPMENT
发育过程中激活素的功能分析
- 批准号:
6476789 - 财政年份:1994
- 资助金额:
$ 35.63万 - 项目类别: